
LIV by WellNow Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: Patients in IL, IN, MI, NY, or PA wanting flat all-inclusive compounded semaglutide
LIV by WellNow is a solid telehealth option with balanced features and pricing.
No insurance needed · Vetted by our editors
LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss. The flat $279 per month price covers medication, injection supplies, and unlimited virtual visits with board-certified online providers, plus same-day approval and monthly home delivery. Eligibility requires age 18+ and a BMI of 30+, or 27+ with a weight-related condition. Compounded semaglutide is not FDA-approved. Service is limited to Illinois, Indiana, Michigan, New York, and Pennsylvania, and insurance is not accepted.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to LIV by WellNow
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
LIV by WellNow at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded semaglutide
- Starting price
- $279/mo
- Availability
- 5 states
- FDA status
- No FDA warning letter on record
How we scored LIV by WellNow
Each dimension is scored algorithmically from LIV by WellNow’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.5/10At $279/mo, LIV by WellNow runs about 65% above the $170 median for GLP-1 providers.
Effectiveness25%
7.8/10LIV by WellNow offers semaglutide, the GLP-1 with the deepest published weight-loss evidence base.
User Experience15%
7.8/10Online intake and platform experience — app/portal-based; 8 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
5.8/10LIV by WellNow operates in a limited 5-state footprint — check availability first.
Support10%
6.1/10LIV by WellNow provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this LIV by WellNow review
Last checked July 2026- Confirmed current pricing across 1 dose/plan tier
- Confirmed availability in 5 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with LIV by WellNow
We walked LIV by WellNow’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an eligibility questionnaire.
- 2A medical provider confirms eligibility.
- 3Medication delivered to home.
- 4Access unlimited virtual visits with board-certified providers.
- Online telehealth (WellNow brand); compounded semaglutide $279/mo shown before intake.
- Footer notes 'clinical evaluation required'; virtual visits included but not stated as mandatory.
- Only compounded semaglutide found; no tirzepatide.
GLP-1 medications LIV by WellNow offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check LIV by WellNow's current pricing and active discounts before you decide.
What we like
- Flat $279/month covers medication, supplies, and unlimited virtual visits
- Backed by established WellNow Urgent Care brand
- Board-certified online medical providers
- Same-day approval and monthly home delivery
- Transparent all-inclusive pricing with no hidden fees
Watch-outs
- Compounded semaglutide is not FDA-approved or evaluated
- Only available in five states (IL, IN, MI, NY, PA)
- No tirzepatide option offered
- Insurance not accepted for compounded semaglutide
LIV by WellNow: one flat price from an urgent-care brand you may already know
LIV by WellNow is the telehealth weight-loss arm of WellNow Urgent Care, the same walk-in clinic chain you might have visited for a strep test or a sprained ankle. That lineage is the whole pitch here. Instead of a standalone startup you've never heard of, you're getting compounded semaglutide from a company with a physical urgent-care footprint and a recognizable name. For the right person, that familiarity plus a single, all-in monthly price makes LIV one of the more straightforward options to understand. The catch is that it only operates in five states and only offers one medication, so it's a narrow fit rather than a universal pick.
How the $279-a-month price actually works
LIV charges one flat rate of $279 per month, and that number is genuinely all-inclusive: it covers the compounded semaglutide itself, the injection supplies you need to administer it, and unlimited virtual visits with the medical team. There's no separate consult fee bolted on, no charge for messaging your provider, and no surprise shipping line item — your monthly home delivery is part of the deal. That simplicity is the appeal. Plenty of telehealth programs advertise a low teaser figure and then layer on membership dues, lab fees, or per-dose medication costs that balloon the real total. LIV skips that game.
What you should know going in is that $279 sits above the category median of roughly $170 a month. So you are paying a premium for the all-inclusive structure and the WellNow name rather than chasing the rock-bottom price. LIV also does not run a discounted first-month promo to lure you in — the price you see is the price from day one. Whether that's worth it depends on how much you value a predictable bill and not having to do math every month. See our scoring methodology for how we weigh transparent pricing like this.
The medication: compounded semaglutide, and only that
LIV dispenses compounded semaglutide, the same active ingredient found in Wegovy and Ozempic, prepared by a compounding pharmacy rather than the brand manufacturer. After a same-day approval, your medication ships to your door each month along with everything you need to inject it. The unlimited virtual visits mean you can check in with a provider as you titrate your dose or if side effects flare up, without watching a meter run.
The honest limitation: LIV offers no tirzepatide. Tirzepatide (the molecule in Zepbound and Mounjaro) tends to drive larger average weight loss in head-to-head data, and many of LIV's competitors offer both. If you've already decided tirzepatide is the route you want, LIV simply isn't your provider — there's no upgrade path here.
What genuinely sets LIV apart
The real differentiator isn't a unique formulation or a rock-bottom price — it's the corporate backing. LIV runs under WellNow Urgent Care, supported by TAG Urgent Care Support Services LLC, which means the brand has real operational infrastructure and a reputation tied to existing brick-and-mortar clinics. The visits are handled by board-certified online providers, and the program's eligibility rules are clearly stated up front: you need to be 18 or older with a BMI of 30 or above, or 27-plus if you have a weight-related condition like high blood pressure or type 2 diabetes. That clarity, paired with same-day approval, makes the on-ramp feel less like a black box than many compounded-semaglutide sellers.
Who should choose LIV — and who should skip it
LIV makes the most sense for a specific person: someone living in Illinois, Indiana, Michigan, New York, or Pennsylvania who wants compounded semaglutide, values a single predictable bill over the absolute lowest price, and likes the reassurance of an established urgent-care brand behind the service.
- Choose LIV if you're in one of its five states, you want everything (medication, supplies, unlimited visits, delivery) folded into one flat payment, and brand familiarity matters to you.
- Skip LIV if you live outside IL, IN, MI, NY, or PA — it simply won't serve you.
- Skip LIV if you want tirzepatide, need insurance to apply, or you're hunting for the cheapest possible monthly cost.
- Skip LIV if you specifically want an FDA-approved branded product rather than a compounded version.
Trust, safety, and the compounding caveat
Here's the part you can't gloss over: LIV's semaglutide is compounded, not FDA-approved or FDA-evaluated, and to its credit LIV states that disclaimer explicitly rather than burying it. Compounded GLP-1s exist in a different regulatory lane than brand-name drugs — they aren't reviewed for safety, effectiveness, or quality the way Wegovy is. That's a real trade-off you accept in exchange for the lower cost and accessibility, and it's true of essentially every compounded-semaglutide telehealth program, not just this one.
On the reassurance side, there are no FDA warning letters on file for LIV, the prescribing is done by board-certified providers, and its five-state availability is verified, which raises our confidence in the operational details. One practical note: insurance is not accepted, so the $279 is an out-of-pocket cost. As with any compounded product, you should confirm the current price, dosing plan, and pharmacy details directly with LIV before you enroll.
Bottom line
LIV by WellNow is a clean, no-surprises way to get compounded semaglutide if you happen to live in one of its five states and you'd rather pay a slightly above-median flat rate than juggle add-on fees. The WellNow urgent-care backing and the all-inclusive $279 pricing are its strongest selling points. But the narrow geographic reach, the semaglutide-only menu with no tirzepatide, and the inherent compounded-drug caveat mean it's a good fit for a specific shopper rather than a default recommendation. If you're outside its footprint or you want more medication choice, look elsewhere; if you're inside it and crave simplicity, LIV earns a serious look.
Shopping around? Direct Meds ($249/month) and MyStart Health ($299/month) are the nearest alternatives to LIV by WellNow in our rankings.
The Bottom Line
LIV by WellNow is a solid telehealth option with balanced features and pricing.
Ready to start with LIV by WellNow?
Starting at $279/month. See current pricing and start your free consultation.
LIV by WellNow might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this LIV by WellNow review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See LIV by WellNow's current pricing
Plans start at $279/month. Start your free consultation to check eligibility and today's price.